The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorTarik Emre Sener
About this trial
The primary aim of this study is to evaluate the role of three specific urinary proteins-RhoA, Nerve Growth Factor (NGF), and Brain-Derived Neurotrophic Factor (BDNF)-as potential biomarkers for the diagnosis and follow-up of children aged 4-18 diagnosed with Overactive Bladder (OAB) and Vitamin D deficiency.
Eligibility criteria
Qualifiers
Children aged 4-18 years presenting with active OAB symptoms (frequency, urgency)
Disqualifiers
Neurological diseases
Malignancy
Active urinary tract infections
Anatomical bladder anomalies
Trial design
Treatments tested in this trial
- Urotherapy
Treatment groups
52 Participants
are divided into 2 treatment groupsSponsors and collaborators
Tarik Emre Sener
Lead sponsor
Marmara University
Sponsor institution
Source ClinicalTrials.gov